3.21
Sight Sciences Inc (SGHT) 最新ニュース
Sight Sciences Announces the Release of its Sustainability Report - GlobeNewswire
Sight Sciences Sustainability Report Reveals Strong Gender Pay Equity, 14% Staff Retention Boost - Stock Titan
Sight Sciences Appoints Gary Burbach to Board of Directors - VisionMonday.com
Sight Sciences appoints new board member By Investing.com - Investing.com India
Sight Sciences appoints new board member - Investing.com
Sight Sciences Appoints Gary Burbach to its Board of Directors - The Manila Times
Sight Sciences Strengthens Board with Medtech Veteran as Glaucoma, Dry Eye Markets Transform - Stock Titan
Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment - Nasdaq
Sight Sciences to Debut OMNI® Edge Surgical System at the - GlobeNewswire
Sight Sciences Unveils OMNI Edge: Next-Gen Glaucoma Surgery System with 2X Capacity | SGHT Stock News - Stock Titan
Sight Sciences, Inc. (NASDAQ:SGHT) Shares Acquired by American Century Companies Inc. - Defense World
Sight Sciences (NASDAQ:SGHT) Earns Hold Rating from Needham & Company LLC - Defense World
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
April 2025's Top Penny Stocks To Watch - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Sight Sciences at 24th Annual Needham Conference: Strategic Growth Insights - Investing.com Canada
Sight sciences chief commercial officer sells $11,641 in stock By Investing.com - Investing.com India
Sight Sciences stock hits 52-week low at $2.13 amid market challenges - Investing.com
Sight sciences chief commercial officer sells $11,641 in stock - Investing.com
Sight sciences CEO Paul Badawi sells shares worth $55,672 By Investing.com - Investing.com Australia
Sight sciences CTO David Badawi sells $13,771 in common stock By Investing.com - Investing.com India
Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 By Investing.com - Investing.com Australia
Sight Sciences CFO Alison Bauerlein sells shares worth $44,787 - Investing.com
Sight sciences CTO David Badawi sells $13,771 in common stock - Investing.com
Sight Sciences chief legal officer sells $21,693 in stock - Investing.com
Sight Sciences chief legal officer sells $21,693 in stock By Investing.com - Investing.com UK
Sight Sciences Executives Sell Shares to Cover Tax Liabilities - TradingView
Sight Sciences stock hits 52-week low at $2.13 amid market challenges By Investing.com - Investing.com South Africa
Sight Sciences, Inc. (NASDAQ:SGHT) Short Interest Update - Defense World
Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st
Sight sciences chief legal officer sells shares worth $19,250 - MSN
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire
Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World
Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia
Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India
Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World
Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World
Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN
Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia
Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail
Sight Sciences Inc. (SGHT) reports earnings - Quartz
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results, Initiates Full Year 2025 Financial Guidance - Vision Monday
Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained - TipRanks
Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges - TipRanks
Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler - TipRanks
Stifel cuts Sight Sciences price target to $4, maintains Buy rating By Investing.com - Investing.com South Africa
Stifel cuts Sight Sciences price target to $4, maintains Buy rating - Investing.com
Sight Sciences Stock Hits 52-Week Low at $2.27 Amid Market Challenges - Investing.com India
大文字化:
|
ボリューム (24 時間):